NYSE:SHW
NYSE:SHWChemicals

Assessing Sherwin-Williams (SHW) Valuation As Pricing Power And Cost Discipline Meet Key Earnings Test

Recent analyst commentary around Sherwin-Williams (SHW) has highlighted the company’s pricing power, brand strength, and cost discipline, with investors now looking to the upcoming earnings release as a key test of those themes. See our latest analysis for Sherwin-Williams. At a share price of $327.84, Sherwin-Williams has seen short term share price returns move slightly in both directions recently, while its 3 year total shareholder return of 42.72% contrasts with a slightly negative 1 year...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun’s Cash Flow And Storage Gains Might Change The Case For Investing In Sunrun (RUN)

In Q3 2025, Sunrun Inc. reported a revenue increase of 35% year over year, a 10% rise in aggregate subscriber value, strong storage adoption, and six consecutive quarters of positive cash flow, supported by US$709 million in unrestricted cash and ongoing access to capital markets. This combination of improving cash generation and storage-led unit economics has strengthened the perception of Sunrun’s business model resilience and long-term value creation potential. Next, we’ll examine how...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Valuation Check After Recent Share Price Softness

Why Coca-Cola stock is on investors’ radar today Coca-Cola (KO) is back in focus after recent trading left the shares with a 1.1% one day decline and slightly lower performance over the past week and month, despite a positive past 3 months. See our latest analysis for Coca-Cola. Zooming out, Coca-Cola’s recent share price softness contrasts with a 1-year total shareholder return of 17.0% and a 5-year total shareholder return of 60.0%. This suggests longer term momentum remains positive even...
NYSE:MIR
NYSE:MIRElectronic

A Look At Mirion Technologies (MIR) Valuation After Its Earnings Beat And Nuclear Power Segment Strength

Mirion Technologies (MIR) has drawn fresh attention after reporting quarterly earnings per share ahead of expectations, along with strong performance in its nuclear power end market, yet the stock has retreated following the announcement. See our latest analysis for Mirion Technologies. The latest earnings news arrives after a mixed stretch in the share price, with a 3.03% 90 day share price return and a 36.25% 1 year total shareholder return suggesting long term momentum, while shorter term...
NYSE:RDN
NYSE:RDNDiversified Financial

A Look At Radian Group (RDN) Valuation As Shares Trade Near Recent Levels

Radian Group (RDN) is back on investors’ radar after recent share price moves. The stock last closed at $35.92, prompting fresh questions about how its mortgage and real estate services business is currently valued. See our latest analysis for Radian Group. While the latest move to $35.92 comes with a modest 1-day share price return of 0.19% decline and a 7-day share price return of 0.99% decline, the share price return over the last 30 and 90 days has been positive. Over the longer term,...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Is JAMA-Lauded Launch-HTN And FDA Feedback Altering The Investment Case For Mineralys Therapeutics (MLYS)?

Mineralys Therapeutics recently advanced its aldosterone synthase inhibitor program as the Phase 3 Launch-HTN trial of Lorundrostat, which showed significant reductions in systolic blood pressure in treatment-resistant hypertension, was recognized in JAMA’s inaugural “Research of the Year,” and the company received FDA pre-NDA feedback supporting a planned New Drug Application submission. This recognition, combined with the prospect of additional Lorundrostat trial readouts expected in 2026,...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Will New HEPZATO KIT Subgroup Data on Tumor Burden and Survival Change Delcath Systems' (DCTH) Narrative

Delcath Systems recently reported publication of subgroup analyses from its phase 3 FOCUS study of the HEPZATO KIT for unresectable metastatic uveal melanoma in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across multiple patient categories. The data highlight that patients with lower tumor burden and low or normal LDH experienced meaningfully longer progression-free and overall survival, with many responses emerging only after several...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Assessing Intuitive Machines (LUNR) Valuation After Recent Share Price Strength

Event driven move in Intuitive Machines stock Intuitive Machines (LUNR) has drawn fresh attention after recent trading saw the share price close at US$17.88, with short term returns over the past week and month outpacing its past year performance. See our latest analysis for Intuitive Machines. The recent move to a US$17.88 share price comes after a sharp 30 day share price return of 59.5% and a 90 day share price return of 51.65%, set against a 1 year total shareholder return decline of...
NYSE:APO
NYSE:APODiversified Financial

Assessing Apollo Global Management’s (APO) Valuation After Mixed Recent Returns And Undervalued Fair Value Estimate

Apollo Global Management (APO) is back in focus after recent trading, with the share price last closing at $146.61. For investors, the key questions now center on returns, earnings trends, and valuation. See our latest analysis for Apollo Global Management. Recent trading has been choppy, with a 1-day share price return of 1.28% and a 30-day share price return of 6.14%. However, the 1-year total shareholder return shows a decline of 12.08%, which contrasts with a very large 3-year total...
NasdaqGM:FCEL
NasdaqGM:FCELElectrical

Assessing FuelCell Energy (FCEL) Valuation After Expanded US$200 Million Stock Sale Plan And Volatile Trading

FuelCell Energy (FCEL) is back in focus after the company amended its open market sales agreement to allow up to US$200 million of additional common stock issuance, a move that has coincided with sharp share price swings. See our latest analysis for FuelCell Energy. The amended share sale plan comes after a sharp share price move, with an 11.76% 1 day share price return at the latest close of US$8.17. However, that sits against a 30 day share price return of 2.39% and a 90 day share price...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Pricing Reflect Its Value After A 40% One Year Share Price Fall

Are you wondering whether Molina Healthcare's share price reflects its true worth, or if the recent swings have opened up an opportunity for you? The stock last closed at US$178.46, with returns of 7.2% over 7 days and 17.5% over 30 days. Over 1 year the return stands at a 40.2% decline, and the 3 year and 5 year returns show 39.8% and 26.2% declines respectively. These moves sit against an ongoing backdrop of attention on managed care providers. Investors keep a close eye on factors such as...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Assessing Mobileye (MBLY) Valuation After Major EyeQ6H Surround ADAS Win With Top U.S. Automaker

Mobileye Global (MBLY) is back in the spotlight after securing a top tier U.S. automaker that plans to roll out its EyeQ6H powered Surround ADAS as standard equipment across millions of vehicles. See our latest analysis for Mobileye Global. The new contract arrives after a difficult stretch for investors, with the 1 year total shareholder return down about 48.6% and the 3 year total shareholder return down roughly 66.4%. At the same time, the 1 day share price return of 7.6% and 7 day share...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Assessing Fermi (FRMI) Valuation After Recent Share Price Rebound And DCF Implied Upside

Fermi’s recent price swings and context for investors Fermi (FRMI) has caught investor attention after a sharp near term rebound, with the stock up 10.25% over the past day and 17.29% over the past week, despite weaker recent month and past 3 months returns. See our latest analysis for Fermi. While the recent 1-day and 7-day share price returns have been strong, the 30-day and 90-day share price returns are weaker. This points to short term momentum improving after a difficult few months...
NYSE:BK
NYSE:BKCapital Markets

A Look At Bank Of New York Mellon Corporation (BK) Valuation After Recent Share Price Momentum

Without a clear single event driving headlines, Bank of New York Mellon Corporation (BK) is drawing attention mainly for its recent share performance and fundamentals, prompting investors to reassess how its current valuation aligns with its business profile. See our latest analysis for Bank of New York Mellon. At a latest share price of US$117.04, BNY’s recent 90 day share price return of 9.45% and 1 year total shareholder return of 53.53% point to momentum that has been building rather than...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Is PagSeguro’s One-Off US$0.12 Dividend Reshaping the Capital Return Story for PAGS?

PagSeguro Digital Ltd. has approved a special cash dividend of US$0.12 per common share, payable on February 27, 2026 to shareholders of record on January 28, 2026, subject to market and company financial conditions. This one-off payout highlights how PagSeguro is using excess capital to supplement existing capital return tools such as its share buyback program. We’ll now examine how this special cash dividend decision interacts with PagSeguro’s capital returns-focused investment narrative...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Is Zoetis (ZTS) Now Priced For Opportunity After Recent Share Price Weakness

This article examines whether Zoetis is now priced for opportunity or still appears expensive after a difficult period, walking through what the numbers indicate about its current value. The share price closed at US$125.92, with a 6.1% gain over the last 30 days and a 23.1% decline over the past year, which may have influenced how the market views its risk and potential. Recent attention on Zoetis has focused on its role in animal health as investors reassess companies linked to long term...
NasdaqGS:COLB
NasdaqGS:COLBBanks

A Look At Columbia Banking System (COLB) Valuation After New Buyback And Increased HoldCo Investment

Columbia Banking System (COLB) is back in focus after authorizing a $700 million share repurchase program and drawing increased interest from institutional investor HoldCo Asset Management, developments that income-focused bank investors are watching closely. See our latest analysis for Columbia Banking System. The share price has been relatively steady at US$28.19, with a 90 day share price return of 7.64% and a 1 year total shareholder return of 8.69%. This suggests momentum is building...
NasdaqGS:HWC
NasdaqGS:HWCBanks

Assessing Hancock Whitney (HWC) Valuation After Recent Share Price Moves And Steady Long Term Returns

Hancock Whitney (HWC) is back on investors’ radar after recent share price moves, with the stock closing at $64.46 as the bank’s longer term return profile draws closer scrutiny. See our latest analysis for Hancock Whitney. The recent 1 day share price return of 1.22% and 30 day share price return of 1.86% sit against a 1 year total shareholder return of 19.27% and 5 year total shareholder return of 88.85%, hinting at steady but not surging momentum. If you are comparing Hancock Whitney with...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM) Valuation Check As Recent Momentum Meets A Near Fair Value Price Tag

Without a specific news headline driving attention today, JPMorgan Chase (JPM) is attracting interest based on its recent share performance, business scale, and profitability. This is prompting investors to reassess how the stock currently trades. See our latest analysis for JPMorgan Chase. At a latest share price of $325.48, JPMorgan Chase’s 30-day share price return of 3.31% and 90-day share price return of 5.78% sit alongside a 1-year total shareholder return of 37.29%. This suggests that...